Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Published on 24 Mar 2023

Risk factors associated with inappropriate empirical antimicrobial treatment in bloodstream infections. A cohort study

in Pharmacology of Infectious Diseases

Beatriz Dietl
Lucía Boix-Palop
Laura Gisbert
Aina Mateu
Gemma Garreta
Mariona Xercavins
Cristina Badía
María López-Sánchez
Josefa Pérez
Esther Calbo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1132530

3,179 views
4 citations

Systematic Review

Published on 24 Mar 2023

Dose optimization of vancomycin in obese patients: A systematic review

in Pharmacology of Infectious Diseases

Mahmoud E. Elrggal
Abdul Haseeb
Manal AlGethamy
Umar Ahsan
Zikria Saleem
Areej Sultan Althaqafi
Sattam Saad Alshuail
Zohair Ahmad Alsiddiqi
Muhammad Shahid Iqbal
Albaraa Faraj Alzahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.965284

12,753 views
4 citations

Systematic Review

Published on 20 Mar 2023

Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Hossein Nateghizad
Rojina Sajadi
Ali Shivaee
Omid Shirazi
Mohadeseh Sharifian
Danyal Abbasi Tadi
Kumarss Amini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1027277

9,666 views
6 citations

Editorial

Published on 16 Mar 2023

Editorial: Advances in antimicrobial therapy and combating resistance

in Pharmacology of Infectious Diseases

Islam M. Ghazi
Wasim S. El Nekidy

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170289

1,358 views
2 citations

Original Research

Published on 15 Mar 2023

Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience

in Pharmacology of Infectious Diseases

Dragana Sokolović
Dragana Drakul
Vesna Vujić‐Aleksić
Bojan Joksimović
Siniša Marić
Lana Nežić

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067973

5,044 views
14 citations

Original Research

Published on 14 Mar 2023

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

in Pharmacology of Infectious Diseases

Rami Ayoun Alsoud
Robin J. Svensson
Elin M. Svensson
Stephen H. Gillespie
Martin J. Boeree
Andreas H. Diacon
Rodney Dawson
Rob E. Aarnoutse
Ulrika S. H. Simonsson

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067295

3,623 views
5 citations

Original Research

Published on 13 Mar 2023

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis

in Pharmacology of Infectious Diseases

Junzhen Wu
Xinyi Yang
Jufang Wu
Jingjing Wang
Hailan Wu
Yu Wang
Hong Yuan
Huahui Yang
Hailin Wang
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1135007

3,220 views
5 citations

Review

Published on 09 Mar 2023

An update on SARS-CoV-2 immunization and future directions

in Pharmacology of Infectious Diseases

Rashmi Rana
Ravi Kant
Tanya Kumra
Sneha Gupta
Devinder Singh Rana
Nirmal Kumar Ganguly

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1125305

4,970 views
10 citations

Clinical Trial

Published on 09 Mar 2023

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

in Pharmacology of Infectious Diseases

Amin Rakhshan
Nazanin Farahbakhsh
Ghamartaj Khanbabaee
Seyed Ahmad Tabatabaii
Saeed Sadr
Maryam Hassanzad
Mohammad Sistanizad
Farzaneh Dastan
Mahmoud Hajipour
Amir Reza Bahadori

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130374

4,930 views
4 citations

Review

Published on 08 Mar 2023

Ebanga™: The most recent FDA-approved drug for treating Ebola

in Pharmacology of Infectious Diseases

Elahe Taki
Roya Ghanavati
Tahereh Navidifar
Shirin Dashtbin
Mohsen Heidary
Marjan Moghadamnia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1083429

14,840 views
25 citations

Original Research

Published on 02 Mar 2023

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

in Pharmacology of Infectious Diseases

Sai Shi
Lei Xie
Sen Ma
Binghong Xu
Hailong An
Sheng Ye
Yaxin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118584

3,002 views
3 citations

Review

Published on 02 Mar 2023

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review

in Pharmacology of Infectious Diseases

Jiamin He
Zheng Zhu
Meiyan Sun
Xiaoning Liu
Junwen Yu
Lin Zhang
Hongzhou Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1013688

3,449 views
2 citations

Original Research

Published on 02 Mar 2023

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study

in Pharmacology of Infectious Diseases

Qian Du
Xin Xi
Jie Dong
Tongyan Zhang
Dongxuan Li
Yuzhu Dong
Wenjun Li
Guili Huang
Jun Zhu
Hailong Ran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128219

1,721 views
3 citations

Original Research

Published on 01 Mar 2023

Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

in Pharmacology of Infectious Diseases

Shaibu Oricha Bello
Abdulmajeed Yunusa
Adamu Ahmed Adamu
Mustapha Umar Imam
Muhammad Bashir Bello
Abdulmalik Shuaibu
Ehimario Uche Igumbor
Zaiyad Garba Habib
Mustapha Ayodele Popoola
Chinwe Lucia Ochu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130828

3,708 views
5 citations

Original Research

Published on 24 Feb 2023

Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control

in Pharmacology of Infectious Diseases

Leonardo da Silva Rangel
Francisco Paiva Machado
Raquel Amaral
Ana Cláudia Rodrigues Da Silva
Marcelo Guerra Santos
José Augusto Albuquerque Dos Santos
Natalia Lidmar Von Ranke
Carlos Rangel Rodrigues
Leandro Rocha
Robson Xavier Faria

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1078936

1,967 views

Review

Published on 24 Feb 2023

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus

in Pharmacology of Infectious Diseases

Xiaoli Li
Yongqing Cai
Qinchuan Xia
Yongqun Liao
Rongxin Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118793

6,624 views
9 citations